ArticlePloS one2011
Nigeria Anopheles vector database: an overview of 100 years' research.
Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 83 citations in OpenAlex.
- Trial
- Diversity and Distribution Patterns of Insects in Nigeria: A GBIF-Based Appraisal.Ecology and evolution · 2026Article
- Anopheles gambiae biting behavior and malaria transmission risk in Simiw, a community located in the coastal forest zone of the Central Region of Ghana.Malaria journal · 2026Article
- Molecular Characterization and transmission indices of malaria vector in a rural community in Osun State south-west Nigeria.Scientific reports · 2026Article
- In vitro larvicidal activity of selected azabenzimidazole and diarylquinoline derivatives against Anopheles gambiae and in silico mechanistic analysis.Molecular diversity · 2026Article
- Article
- Identification of the Anopheles marshallii group and vector species composition in the forest ecozone of Akwa Ibom State, Southern Nigeria.Malaria journal · 2025Article
- A review of the performance of the early warning alert and response system (EWARS) in conflict-affected Borno State, Nigeria: a five-year descriptive analysis.Conflict and health · 2025Article
- Modelling species distribution of Anopheles gambiae s.l. in Osun state using random forest modeling approach.Scientific reports · 2025Article
- Article
- Implementation of malaria vector surveillance and insecticide resistance monitoring interventions in Nigeria.Global health research and policy · 2024Article
- Effects of Hurricane Irma on mosquito abundance and species composition in a metropolitan Gulf coastal city, 2016-2018.Scientific reports · 2024Article
- Sibling species of the major malaria vector Anopheles gambiae display divergent preferences for aquatic breeding sites in southern Nigeria.Malaria journal · 2024Article
- Article
- Geospatial modelling of lymphatic filariasis and malaria co-endemicity in Nigeria.International health · 2023Article
- Spatial distribution and ecological niche modeling of geographical spread of Anopheles gambiae complex in Nigeria using real time data.Scientific reports · 2023Article
- Utilization of insecticide-treated nets and associated factors among childbearing women in Northern Nigeria.Malaria journal · 2023Article
- Toxicity of insecticidal plant oils on the larval and adult stages of a major malaria vector (Anopheles gambiae Giles 1920).Parasitology research · 2023Article
- High pyrethroid-resistance intensity in Culex quinquefasciatus (Say) (Diptera: Culicidae) populations from Jigawa, North-West, Nigeria.PLoS neglected tropical diseases · 2022Article
- Mosquito control at a tertiary teaching hospital in Nigeria.Infection prevention in practice · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
Abstract
Anopheles mosquitoes are important vectors of malaria and lymphatic filariasis (LF), which are major public health diseases in Nigeria. Malaria is caused by infection with a protozoan parasite of the genus Plasmodium and LF by the parasitic worm Wuchereria bancrofti. Updating our knowledge of the Anopheles species is vital in planning and implementing evidence based vector control programs. To present a comprehensive report on the spatial distribution and composition of these vectors, all published data available were collated into a database. Details recorded for each source were the locality, latitude/longitude, time/period of study, species, abundance, sampling/collection methods, morphological and molecular species identification methods, insecticide resistance status, including evidence of the kdr allele, and P. falciparum sporozoite rate and W. bancrofti microfilaria prevalence. This collation resulted in a total of 110 publications, encompassing 484,747 Anopheles mosquitoes in 632 spatially unique descriptions at 142 georeferenced locations being identified across Nigeria from 1900 to 2010. Overall, the highest number of vector species reported included An. gambiae complex (65.2%), An. funestus complex (17.3%), An. gambiae s.s. (6.5%). An. arabiensis (5.0%) and An. funestus s.s. (2.5%), with the molecular forms An. gambiae M and S identified at 120 locations. A variety of sampling/collection and species identification methods were used with an increase in molecular techniques in recent decades. Insecticide resistance to pyrethroids and organochlorines was found in the main Anopheles species across 45 locations. Presence of P. falciparum and W. bancrofti varied between species with the highest sporozoite rates found in An. gambiae s.s, An. funestus s.s. and An. moucheti, and the highest microfilaria prevalence in An. gambiae s.l., An. arabiensis, and An. gambiae s.s. This comprehensive geo-referenced database provides an essential baseline on Anopheles vectors and will be an important resource for malaria and LF vector control programmes in Nigeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.